From: Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma
Basal
Post-treatment
P-value
Weight (kg)
71.0 ± 13.1
74.5 ± 13.9
0.0001
BMI (kg/m2)
26.7 ± 4.9
27.0 ± 3.4
0.660
Testosterone (ng/dL)
527 ± 226
< 12
0.001
PSA (ng/mL)
361 ± 508
13 ± 21